[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100590287":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":27,"responsibleParty":44,"collaborators":20,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":20,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":20,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":67,"overallStatus":30,"whyStopped":20,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Northwell Health","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Embozene Microspheres for Facetogenic Low Back Pain","EXPERIMENTAL","This is a single site, single arm study to assess the safety and efficacy of trans arterial embolization using Embozene microspheres of the facet joint for the treatment of facetogenic low back pain.",[13],"Device: Spinal angiography and embolization\u002F Embozene Microspheres",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Spinal angiography and embolization\u002F Embozene Microspheres","Once consent is obtained the patient will be scheduled for spinal angiography and embolization. The patient will undergo the procedure at North Shore University Hospital. After embolization the patient will be monitored in recovery for 5 hours and then discharged to home.\n\nThe primary objective of this study is to examine the safety and feasibility of trans arterial embolization of the facet joint using Embozene Microspheres for the treatment of back pain from facet arthropathy and osteoarthritis.",[9],null,[22],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Betsy Moclair","CONTACT","516-253-7753","bmoclair@northwell.edu",[28],{"facility":29,"status":30,"city":31,"state":32,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"North Shore University Hospital","RECRUITING","Manhasset","New York","11030","United States","US",{"type":37,"coordinates":38},"Point",[39,40],-73.69957,40.79788,{"lat":40,"lon":39},[43],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},{"type":45,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100590287","trans-arterial-embolization-for-the-treatment-of-facet-pain-due-to-facet-arthropathy-100590287",false,"NCT06965452","Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy","Trans Arterial Embolization for Facet Arthropathy","Inclusion Criteria:\n\n* Age 18-85\n\n  * Confirmed diagnosis of spinal facet arthropathy on MRI OR CT\n  * Confirmed diagnosis of lumbosacral facetogenic pain based on diagnostic nerve blocks.\n  * Failed medical management of pain.\n\n    * Back pain persistent for at least 6 months\n    * Pain worse than at least 6\u002F10 on a visual analog pain scale\n  * Failed at least one of either intra-articular injections of steroids\u002F anesthetics or neuro-ablative procedure.\n  * Maximum of 2 spinal levels of facetogenic pain in the lumbar and sacral spine (i.e. L4-5 and L5-S1).\n  * Modified Rankin Scale 0-2\n\nExclusion Criteria:\n\n* \\- Pregnancy\n* History of prior spinal embolization at the target level.\n* History of surgery\u002F stenting of the aorta at the level of embolization.\n* Severe allergic reaction to iodinated contrast (i.e. anaphylaxis)\n* Creatinine \\> 1.5 mg\u002Fdl and\u002For creatinine clearance \\\u003C 60 mL\u002Fmin (except if patients is already on hemodialysis).\n* Modified Rankin Scale \\>2\n* Angiographic\u002F Procedural Exclusion Criterion: Vascular supply to the spinal cord from the vessels supplying the facet joints targeted for embolization.","ALL","18 Years","85 Years",{"count":57,"type":58},40,"ESTIMATED","INTERVENTIONAL",[61],"NA","This single-site, single-arm study evaluates the feasibility, safety, tolerability, and efficacy of trans-arterial embolization (TAE) using Embozene microparticles for treating facetogenic pain due to facet arthropathy (osteoarthritis of the facet joints) in the lumbar spine.",[64,65,66],"Facet Joint Arthropathy","Pain","Osteoarthritis",[68,69,70,71,72],"Facetogenic pain","Facet pain","Facet joint pain","Low back pain","Back Pain","2025-08-14",{"date":75,"type":76},"2025-08-19","ACTUAL",{"date":78,"type":76},"2025-08-12",{"date":80,"type":58},"2026-08-01",{"name":5,"class":6},1]